Literature DB >> 9749485

Comparing treatments for localized prostate cancer--persisting uncertainty.

G W Chodak.   

Abstract

Entities:  

Mesh：

Year:  1998        PMID： 9749485     DOI： 10.1001/jama.280.11.1008

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  4 in total

1.  Patients with prostate cancer treated by ADT have significantly higher fibrinogenemia than healthy control.

Authors:  Stanislav Ziaran; Frederico Manuel Goncalves; Jan Breza
Journal:  World J Urol       Date:  2012-08-17       Impact factor: 4.226

2.  A phase III clinical trial of exercise modalities on treatment side-effects in men receiving therapy for prostate cancer.

Authors:  Robert U Newton; Dennis R Taaffe; Nigel Spry; Robert A Gardiner; Gregory Levin; Bradley Wall; David Joseph; Suzanne K Chambers; Daniel A Galvão
Journal:  BMC Cancer       Date:  2009-06-29       Impact factor: 4.430

3.  Agreement between prostate cancer patients and their clinicians about utilities and attribute importance.

Authors:  Arthur S Elstein; Gretchen B Chapman; Joan S Chmiel; Sara J Knight; Cheeling Chan; Robert B Nadler; Timothy M Kuzel; Amy K Siston; Charles L Bennett
Journal:  Health Expect       Date:  2004-06       Impact factor: 3.377

4.  Reduced Cardiovascular Capacity and Resting Metabolic Rate in Men with Prostate Cancer Undergoing Androgen Deprivation: A Comprehensive Cross-Sectional Investigation.

Authors:  Bradley A Wall; Daniel A Galvão; Naeem Fatehee; Dennis R Taaffe; Nigel Spry; David Joseph; Robert U Newton
Journal:  Adv Urol       Date:  2015-10-26
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.